找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Biopharmaceutics Applications in Drug Development; Rajesh Krishna,Lawrence Yu Book 2008 Springer-Verlag US 2008 absorption.bioequivalence.

[復(fù)制鏈接]
查看: 53901|回復(fù): 51
樓主
發(fā)表于 2025-3-21 18:14:34 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱(chēng)Biopharmaceutics Applications in Drug Development
影響因子2023Rajesh Krishna,Lawrence Yu
視頻videohttp://file.papertrans.cn/189/188319/188319.mp4
發(fā)行地址discusses state of the art knowledge in biopharmaceutics.identifies key issues and opportunities in a distinct problem-solving approach
圖書(shū)封面Titlebook: Biopharmaceutics Applications in Drug Development;  Rajesh Krishna,Lawrence Yu Book 2008 Springer-Verlag US 2008 absorption.bioequivalence.
影響因子.Drug performance is a vital aspect of new drug development as it draws on interdisciplinary expertise from both pharmaceutics and pharmacokinetics disciplines. It is at the key interface that the discipline of biopharmaceutics has emerged. The past two decades have witnessed considerable advances in biopharmaceutics, particularly with regard to bioavailability/bioequivalence, product quality and regulatory standards of approval...Biopharmaceutics Applications in Drug Development presents readers with step-wise, detail-conscious information to develop quality pharmaceuticals. It is composed of carefully crafted sections introducing key concepts and advances in the areas of dissolution, BA/BE, BCS, IVIC, and product quality, with specific focus on integration of regulatory considerations and case histories highlighting the biopharmaceutics strategies adopted in development of successful drugs. .
Pindex Book 2008
The information of publication is updating

書(shū)目名稱(chēng)Biopharmaceutics Applications in Drug Development影響因子(影響力)




書(shū)目名稱(chēng)Biopharmaceutics Applications in Drug Development影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Biopharmaceutics Applications in Drug Development網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Biopharmaceutics Applications in Drug Development網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Biopharmaceutics Applications in Drug Development被引頻次




書(shū)目名稱(chēng)Biopharmaceutics Applications in Drug Development被引頻次學(xué)科排名




書(shū)目名稱(chēng)Biopharmaceutics Applications in Drug Development年度引用




書(shū)目名稱(chēng)Biopharmaceutics Applications in Drug Development年度引用學(xué)科排名




書(shū)目名稱(chēng)Biopharmaceutics Applications in Drug Development讀者反饋




書(shū)目名稱(chēng)Biopharmaceutics Applications in Drug Development讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:30:26 | 只看該作者
板凳
發(fā)表于 2025-3-22 00:46:47 | 只看該作者
Bioavailability and Bioequivalence,lay a significant role in the discovery, development, and regulation of new drug products. Additionally, bioequivalence studies are a crucial component of abbreviated new drug applications (ANDAs), leading to market access of safe, effective, and low cost generic drugs.
地板
發(fā)表于 2025-3-22 07:16:22 | 只看該作者
fully crafted sections introducing key concepts and advances in the areas of dissolution, BA/BE, BCS, IVIC, and product quality, with specific focus on integration of regulatory considerations and case histories highlighting the biopharmaceutics strategies adopted in development of successful drugs. .978-1-4419-4434-4978-0-387-72379-2
5#
發(fā)表于 2025-3-22 10:34:12 | 只看該作者
Christian Werner,Volker Klein,Konradin Webervailability assessment, highlight issues regarding their utilities and limitations, and review challenges of improving some of these current dissolution methods, particularly those used for assessing . drug product performance. In this chapter, we first provide some background information on dissolu
6#
發(fā)表于 2025-3-22 16:58:02 | 只看該作者
7#
發(fā)表于 2025-3-22 17:39:41 | 只看該作者
R. Bombach,B. Hemmerling,W. Kreutnerlay a significant role in the discovery, development, and regulation of new drug products. Additionally, bioequivalence studies are a crucial component of abbreviated new drug applications (ANDAs), leading to market access of safe, effective, and low cost generic drugs.
8#
發(fā)表于 2025-3-22 23:47:58 | 只看該作者
9#
發(fā)表于 2025-3-23 01:58:58 | 只看該作者
10#
發(fā)表于 2025-3-23 09:31:12 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 13:43
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
内丘县| 蓝田县| 大余县| 池州市| 静安区| 东城区| 绵竹市| 南通市| 健康| 碌曲县| 陇川县| 聊城市| 搜索| 淅川县| 孟村| 赣州市| 江川县| 靖江市| 都江堰市| 龙山县| 鄂温| 平罗县| 东明县| 漾濞| 壶关县| 大悟县| 墨竹工卡县| 禄丰县| 锡林浩特市| 鹿泉市| 抚宁县| 肃宁县| 乌兰察布市| 弋阳县| 凤山县| 宾川县| 阆中市| 达孜县| 岳阳县| 苍山县| 柘荣县|